Products and Services

Device maker Nemera has announced the opening of its new headquarters building in Lyons, France. According to the company, the new BREEAM-certified building will also be home to the company's European innovation teams. Nemera also has an innovation center located in the US. The company develops and manufactures a wide range of OINDPs, including nasal spray pumps, … [Read more...] about Nemera opens new headquarters

Aptar Pharma said that it has acquired US-based design firm Metaphase Design Group and will integrate the company into its subsidiary Noble, which Aptar acquired in 2019. Noble launched its Human Factors Plus (HF+) services for combination product development in 2021, and Aptar Pharma says that Metaphase's capabilities will complement Noble's offerings. Metaphase … [Read more...] about Aptar Pharma acquires HF specialist Metaphase Design Group

The University of Glasgow announced that Innovate UK has awarded a university spinout, Acu-Flow, £1 million for development of the company's Nebu-Flow surface acoustic wave nebulizer technology. The University said that its researchers will work with Acu-Flow and the NIHR Devices for Dignity Med-tech Cooperative to have a working nebulizer ready for manufacturing … [Read more...] about Innovate UK awards £1 million grant to Acu-Flow for development of Nebu-Flow technology

Aptar Pharma announced that it has acquired worldwide rights to Pharmaxis’ high payload Orbital dry powder inhaler. In August 2021, the company said that it had acquired an option to purchase the rights to the Orbital DPI and that it had 12 months to decide whether or not to exercise that option. The Orbital inhaler can handle total doses up to 400 mg and was … [Read more...] about Aptar Pharma acquires rights to Pharmaxis’ Orbital DPI

According to Inhalation Sciences (ISAB), the FDA will provide up to $500,000 over two years to fund a study intended to validate ISAB's DissolvIt in vitro lung simulation model for dissolution testing of inhaled drugs. The company said that the agency's National Center for Toxicological Research has approved the research proposal, and the study is expected to begin … [Read more...] about FDA to provide funding for study to validate Inhalation Sciences’ DissolvIt lung simulation model for dissolution testing of inhaled drugs

DPI developer Iconovo announced that it has received a $883,800 grant from the Bill & Melinda Gates Foundation for development of a nasal inhaler based on the company's ICOone single dose device. In March 2021, Iconovo announced that it was developing a nasal version of the ICOone inhaler for use with an ISR COVID-19 vaccine and later said that it had received an … [Read more...] about Iconovo gets grant from Gates Foundation for development of nasal DPI